The board's work

Board proceedings during 2024

The Board held thirteen meetings in 2024. Five of these were physical meetings held at Alleima’s premises in Sandviken or Stockholm, one was a physical meeting held during the Board’s annual trip to one of Alleima’s other production facilities, six meetings were virtual and one meeting was held per capsulam. In advance of each meeting, an agenda and related pre-read materials were circulated to the Board members. The President and CEO routinely reported to the Board regarding the company’s development, financial results and market conditions. The Board approved the company’s strategy for 2024–2028, and then regularly followed up on the company’s implementation of the strategy. The Division Presidents also presented the current strategies of their respective operations to the Board. During the year, the Board approved a number of major investments that expanded Alleima’s production capacity and capabilities as well as the acquisition of medical technology manufacturer Endox, with operations in Germany and Poland. Furthermore, the Board routinely oversaw the company’s financial reporting and dissemination of information to the market to ensure that they were of good quality and accurately reflected the company’s financial position. Reports from the Audit and Remuneration Committees were routinely addressed, and the Board met with the company’s auditor to discuss the auditor’s observations on the audit activities for the year. The Board also reviewed the company’s work in the areas of internal control, risk management, sustainability and compliance, and conducted an annual review of the Group’s Code of Conduct and other policies. During the year, particular attention was devoted to oversight of the company’s preparations for starting sustainability reporting in 2025 in accordance with the EU Corporate Sustainability Reporting Directive (CSRD), which has been enacted in Swedish law. In the fall of 2024, the Board visited Alleima’s operations at its Kanthal division in Mörfelden-Walldorf, Germany.

Remuneration of the Board

As resolved at the 2025 Annual General Meeting, the fee to the Chairman of the Board is SEK 1,530,000 and the fee to each of the non-executive Board members elected by the General Meeting is SEK 530,000.

In addition, SEK 230,000 will be paid to the Chairman of the Audit Committee and SEK 114,000 to each of the other Committee members, in total SEK 458,000. The Chairman of the Remuneration Committee was paid SEK 112,000 and each of the other Committee members SEK 79,000, in total SEK 191,000.

For more detailed information on the remuneration of the Board members, please refer to note 3.5 in the 2024 Annual Report (PDF, 8.8 MB)

Evaluation of the work of the Board

In 2024, the evaluation, which was led by the Chairman of the Board, was carried out by way of each Board member responding anonymously to an online questionnaire. The Chairman also held separate evaluation discussions with each of the Board members. The compiled results of the evaluations were presented to the Board and the Nomination Committee.

Attendance at Board and Committee Meetings in 2024

1) Including per capsulam resolutions in which deputies did not partake.
2) Full attendance starting from election at 2024 AGM.